BDMD Stock Summary and Trading Ideas (Baird Medical Investment Holdings - Ordinary Share | NASDAQ:BDMD)

Baird Medical Investment Holdings Ltd is one of the microwave ablation medical device developers and providers in the PRC for minimally invasive treatment of tumors. Its proprietary medical devices are used for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps. Microwave ablation is a minimally invasive treatment technique that denaturalizes and coagulates the protein of tumor cells with extreme heat generated by microwave energy. Microwave ablation treatments have been applied to benign and malignant tumors, and the company believes the products are safer, minimally invasive and easier to operate with faster recovery periods and lower complication rates for patients, as compared to traditional treatment methods.

Baird Medical Investment Holdings - Ordinary Share trades on the NASDAQ stock market under the symbol BDMD.

As of January 6, 2026, BDMD stock price declined to $1.29 with 58,745 million shares trading.

BDMD has a beta of -1.95, meaning it tends to be less sensitive to market movements. BDMD has a correlation of 0.04 to the broad based SPY ETF.

BDMD has a market cap of $47.38 million. This is considered a Sub-Micro Cap stock.

BDMD has underperformed the market in the last year with a price return of -78.6% while the SPY ETF gained +18.1%. BDMD has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -36.8% and -9.2%, respectively, while the SPY returned +3.7% and +1.0%, respectively.

BDMD support price is $1.23 and resistance is $1.37 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BDMD shares will trade within this expected range on the day.